NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.330
+0.060 (2.64%)
At close: May 29, 2026, 4:00 PM EDT
2.290
-0.040 (-1.72%)
After-hours: May 29, 2026, 7:52 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $9.7 million as of May 29, 2026. Its market cap has increased by 4,748.58% in one year.
Market Cap
9.70M
Enterprise Value
-17.83M
1-Year Change
4,748.58%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $9.70M, a decrease of -98.11%. That is a compound annual growth rate of -36.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 9.70M | -35.33% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 10.71M |
| Aprea Therapeutics | 10.70M |
| BioCardia | 10.52M |
| Bolt Biotherapeutics | 10.09M |
| Psyence Biomedical | 9.52M |
| Curanex Pharmaceuticals | 9.43M |
| Immuron | 9.40M |
| Soligenix | 9.38M |